<?xml version='1.0' encoding='UTF-8'?>
<extracted-tables-set><pmcid>7380082</pmcid><all-ids><article-id xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" pub-id-type="pmid">32765403</article-id><article-id xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" pub-id-type="pmc">7380082</article-id><article-id xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" pub-id-type="doi">10.3389/fneur.2020.00684</article-id></all-ids><extracted-table><table-id>T1</table-id><table-label>Table 1</table-label><table-caption>Demographic and clinical characteristics of patient groups.</table-caption><original-table><table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="T1" position="float"><label>Table 1</label><caption><p>Demographic and clinical characteristics of patient groups.</p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="top" align="left" rowspan="1" colspan="1"><bold>Demographic and clinical characteristics</bold></th><th valign="top" align="center" rowspan="1" colspan="1"><bold>GRE (<italic>n =</italic> 15)</bold></th><th valign="top" align="center" rowspan="1" colspan="1"><bold>Non-GRE (<italic>n =</italic> 15)</bold></th><th valign="top" align="center" rowspan="1" colspan="1"><bold>Healthy (<italic>n =</italic> 20)</bold></th><th valign="top" align="center" rowspan="1" colspan="1"><bold><italic>p</italic>-value</bold></th></tr></thead><tbody><tr><td valign="top" align="left" colspan="5" rowspan="1"><bold>Sex</bold></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">   Male</td><td valign="top" align="center" rowspan="1" colspan="1">8</td><td valign="top" align="center" rowspan="1" colspan="1">7</td><td valign="top" align="center" rowspan="1" colspan="1">9</td><td valign="top" align="center" rowspan="1" colspan="1">0.88</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">   Female</td><td valign="top" align="center" rowspan="1" colspan="1">7</td><td valign="top" align="center" rowspan="1" colspan="1">8</td><td valign="top" align="center" rowspan="1" colspan="1">11</td><td rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><bold>Age (y)<xref ref-type="table-fn" rid="TN1"><sup>*</sup></xref></bold></td><td valign="top" align="center" rowspan="1" colspan="1">38.2 ± 3.4</td><td valign="top" align="center" rowspan="1" colspan="1">41.4 ± 3.1</td><td valign="top" align="center" rowspan="1" colspan="1">38.0 ± 1.9</td><td valign="top" align="center" rowspan="1" colspan="1">0.63</td></tr><tr><td valign="top" align="left" colspan="5" rowspan="1"><bold>Handness</bold></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">   Right</td><td valign="top" align="center" rowspan="1" colspan="1">15</td><td valign="top" align="center" rowspan="1" colspan="1">15</td><td valign="top" align="center" rowspan="1" colspan="1">20</td><td valign="top" align="center" rowspan="1" colspan="1">−</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">   Left</td><td valign="top" align="center" rowspan="1" colspan="1">0</td><td valign="top" align="center" rowspan="1" colspan="1">0</td><td valign="top" align="center" rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" colspan="5" rowspan="1"><bold>KPS score (preoperative)</bold></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">   100</td><td valign="top" align="center" rowspan="1" colspan="1">15</td><td valign="top" align="center" rowspan="1" colspan="1">14</td><td valign="top" align="center" rowspan="1" colspan="1">20</td><td rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">   90~100</td><td valign="top" align="center" rowspan="1" colspan="1">0</td><td valign="top" align="center" rowspan="1" colspan="1">1</td><td valign="top" align="center" rowspan="1" colspan="1">0</td><td valign="top" align="center" rowspan="1" colspan="1">&gt; 0.99</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">   80~90</td><td valign="top" align="center" rowspan="1" colspan="1">0</td><td valign="top" align="center" rowspan="1" colspan="1">0</td><td valign="top" align="center" rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><bold>Education level (y)<xref ref-type="table-fn" rid="TN1"><sup>*</sup></xref></bold></td><td valign="top" align="center" rowspan="1" colspan="1">12.8 ± 1.2</td><td valign="top" align="center" rowspan="1" colspan="1">13.2 ± 1.1</td><td valign="top" align="center" rowspan="1" colspan="1">12.7 ± 0.8</td><td valign="top" align="center" rowspan="1" colspan="1">0.13</td></tr><tr><td valign="top" align="left" colspan="5" rowspan="1"><bold>Histopathology</bold></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">   Astrocytoma</td><td valign="top" align="center" rowspan="1" colspan="1">7</td><td valign="top" align="center" rowspan="1" colspan="1">8</td><td valign="top" align="center" rowspan="1" colspan="1">–</td><td valign="top" align="center" rowspan="1" colspan="1">0.71</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">   Oligodendroglioma</td><td valign="top" align="center" rowspan="1" colspan="1">8</td><td valign="top" align="center" rowspan="1" colspan="1">7</td><td valign="top" align="center" rowspan="1" colspan="1">–</td><td rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" colspan="5" rowspan="1"><bold>IDH status</bold></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">   Mutation</td><td valign="top" align="center" rowspan="1" colspan="1">9</td><td valign="top" align="center" rowspan="1" colspan="1">10</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">   Wild-type</td><td valign="top" align="center" rowspan="1" colspan="1">6</td><td valign="top" align="center" rowspan="1" colspan="1">5</td><td rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">0.71</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><bold>Tumor volume (mL)<xref ref-type="table-fn" rid="TN1"><sup>*</sup></xref></bold></td><td valign="top" align="center" rowspan="1" colspan="1">44.83 ± 8.37</td><td valign="top" align="center" rowspan="1" colspan="1">38.57 ± 10.16</td><td valign="top" align="center" rowspan="1" colspan="1">–</td><td valign="top" align="center" rowspan="1" colspan="1">0.64</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><bold>Onset age (y)<xref ref-type="table-fn" rid="TN1"><sup>*</sup></xref></bold></td><td valign="top" align="center" rowspan="1" colspan="1">38.15 ± 1.9</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">–</td></tr><tr><td valign="top" align="left" colspan="5" rowspan="1"><bold>Frequency before diagnosis</bold></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">   Low (only once)</td><td valign="top" align="center" rowspan="1" colspan="1">12</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">   Medium (2~3 times)</td><td valign="top" align="center" rowspan="1" colspan="1">2</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">–</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">   High (&gt;3 times)</td><td valign="top" align="center" rowspan="1" colspan="1">1</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><bold>Preoperative anti-epileptic drugs</bold></td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">–</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">   Levetiracetam (0.5 g, twice a day)</td><td valign="top" align="center" rowspan="1" colspan="1">15</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"><bold>Postoperative epileptic control</bold></td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1">–</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">   Engel Class I</td><td valign="top" align="center" rowspan="1" colspan="1">15</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr></tbody></table><table-wrap-foot><fn id="TN1"><label>*</label><p><italic>Values are means ± standard deviations, unless indicated otherwise</italic>.</p></fn><p><italic>Using Mann-Whitney U test to compare differences in the Karnofsky performance status between the GRE and non- GRE groups</italic>.</p><p><italic>Using Student's t-test to compare differences in tumor volume between the GRE and non-GRE groups</italic>.</p><p><italic>Using one-way ANOVA test to compare differences in age and education level between the GRE and non-GRE groups</italic>.</p><p><italic>Using chi-squared test to compare differences in sex, tumor location, and IDH status between the GRE and non-GRE groups</italic>.</p><p><italic>IDH, isocitrate dehydrogenase; KPS, Karnofsky performance status</italic>.</p></table-wrap-foot></table-wrap></original-table><transformed-table>Table 1<div xmlns="http://www.w3.org/1999/xhtml" class="caption">Demographic and clinical characteristics of patient groups.</div><div xmlns="http://www.w3.org/1999/xhtml" class="table"><table frame="hsides" rules="groups"><thead><tr><th valign="top" align="left">Demographic and clinical characteristics</th><th valign="top" align="center">GRE (n = 15)</th><th valign="top" align="center">Non-GRE (n = 15)</th><th valign="top" align="center">Healthy (n = 20)</th><th valign="top" align="center">p-value</th></tr></thead><tbody><tr><td valign="top" align="left" colspan="5">Sex</td></tr><tr><td valign="top" align="left">   Male</td><td valign="top" align="center">8</td><td valign="top" align="center">7</td><td valign="top" align="center">9</td><td valign="top" align="center">0.88</td></tr><tr><td valign="top" align="left">   Female</td><td valign="top" align="center">7</td><td valign="top" align="center">8</td><td valign="top" align="center">11</td><td/></tr><tr><td valign="top" align="left">Age (y)???</td><td valign="top" align="center">38.2 ± 3.4</td><td valign="top" align="center">41.4 ± 3.1</td><td valign="top" align="center">38.0 ± 1.9</td><td valign="top" align="center">0.63</td></tr><tr><td valign="top" align="left" colspan="5">Handness</td></tr><tr><td valign="top" align="left">   Right</td><td valign="top" align="center">15</td><td valign="top" align="center">15</td><td valign="top" align="center">20</td><td valign="top" align="center">−</td></tr><tr><td valign="top" align="left">   Left</td><td valign="top" align="center">0</td><td valign="top" align="center">0</td><td valign="top" align="center">0</td><td/></tr><tr><td valign="top" align="left" colspan="5">KPS score (preoperative)</td></tr><tr><td valign="top" align="left">   100</td><td valign="top" align="center">15</td><td valign="top" align="center">14</td><td valign="top" align="center">20</td><td/></tr><tr><td valign="top" align="left">   90~100</td><td valign="top" align="center">0</td><td valign="top" align="center">1</td><td valign="top" align="center">0</td><td valign="top" align="center">&gt; 0.99</td></tr><tr><td valign="top" align="left">   80~90</td><td valign="top" align="center">0</td><td valign="top" align="center">0</td><td valign="top" align="center">0</td><td/></tr><tr><td valign="top" align="left">Education level (y)???</td><td valign="top" align="center">12.8 ± 1.2</td><td valign="top" align="center">13.2 ± 1.1</td><td valign="top" align="center">12.7 ± 0.8</td><td valign="top" align="center">0.13</td></tr><tr><td valign="top" align="left" colspan="5">Histopathology</td></tr><tr><td valign="top" align="left">   Astrocytoma</td><td valign="top" align="center">7</td><td valign="top" align="center">8</td><td valign="top" align="center">–</td><td valign="top" align="center">0.71</td></tr><tr><td valign="top" align="left">   Oligodendroglioma</td><td valign="top" align="center">8</td><td valign="top" align="center">7</td><td valign="top" align="center">–</td><td/></tr><tr><td valign="top" align="left" colspan="5">IDH status</td></tr><tr><td valign="top" align="left">   Mutation</td><td valign="top" align="center">9</td><td valign="top" align="center">10</td><td/><td/></tr><tr><td valign="top" align="left">   Wild-type</td><td valign="top" align="center">6</td><td valign="top" align="center">5</td><td/><td valign="top" align="left">0.71</td></tr><tr><td valign="top" align="left">Tumor volume (mL)???</td><td valign="top" align="center">44.83 ± 8.37</td><td valign="top" align="center">38.57 ± 10.16</td><td valign="top" align="center">–</td><td valign="top" align="center">0.64</td></tr><tr><td valign="top" align="left">Onset age (y)???</td><td valign="top" align="center">38.15 ± 1.9</td><td/><td/><td valign="top" align="left">–</td></tr><tr><td valign="top" align="left" colspan="5">Frequency before diagnosis</td></tr><tr><td valign="top" align="left">   Low (only once)</td><td valign="top" align="center">12</td><td/><td/><td/></tr><tr><td valign="top" align="left">   Medium (2~3 times)</td><td valign="top" align="center">2</td><td/><td/><td valign="top" align="left">–</td></tr><tr><td valign="top" align="left">   High (&gt;3 times)</td><td valign="top" align="center">1</td><td/><td/><td/></tr><tr><td valign="top" align="left">Preoperative anti-epileptic drugs</td><td/><td/><td/><td valign="top" align="left">–</td></tr><tr><td valign="top" align="left">   Levetiracetam (0.5 g, twice a day)</td><td valign="top" align="center">15</td><td/><td/><td/></tr><tr><td valign="top" align="left">Postoperative epileptic control</td><td/><td/><td/><td valign="top" align="left">–</td></tr><tr><td valign="top" align="left">   Engel Class I</td><td valign="top" align="center">15</td><td/><td/><td/></tr></tbody></table></div>*Values are means ± standard deviations, unless indicated otherwise.Using Mann-Whitney U test to compare differences in the Karnofsky performance status between the GRE and non- GRE groups.Using Student's t-test to compare differences in tumor volume between the GRE and non-GRE groups.Using one-way ANOVA test to compare differences in age and education level between the GRE and non-GRE groups.Using chi-squared test to compare differences in sex, tumor location, and IDH status between the GRE and non-GRE groups.IDH, isocitrate dehydrogenase; KPS, Karnofsky performance status.</transformed-table></extracted-table></extracted-tables-set>